Sharp Weitlaner Retractor

...ional reference laboratory and a worldwide leader ... ARUP offers an extensive test menu of highly comp...mic pathology. Owned by the University of Utah, AR... the nation's university teaching hospitals and ch...

Medicine Products:

Urethral Washing for Cytology Urea Breath Test Tyrosine, Plasma Type & RH

(Date:9/4/2008)...ase-control study, the presence of measles virus R...GI disturbances than in children with only GI dist...t were unrelated to MMR vaccine timing. Study fin...f Science on September 4 ( http://dx.plos.org/10....ementation of measles vaccines in 1963, three to f...

(Date:9/4/2008)...of instructions they say could help doctors evalua...y News) -- Vaccine safety experts say that almost ...vaccinations with close monitoring and a set of st...er issue of Pediatrics , a team of experts led by...tep-by-step set of instructions -- an algorithm --...

(Date:9/4/2008)...abeling about fungal infection risk , ,...lth authorities have asked the manufacturers of fo...safety warnings on the risk of developing opportun...imzia, Enbrel and Remicade, belong to a class of m...ockers (TNF-alpha blockers), which suppress the im...

(Date:9/4/2008)...Pavilions are Sold-Out and Sustainable Packaging ... YORK, Sept. 4 /PRNewswire/ -- The latest innovati...s products, and sustainable,packaging will be on f...o.com ),September 9, 10, 11 at the Jacob K. Javit...l and Naturals Pavilions at the event are sold-out...

Breaking Medicine News(10 mins):Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2 Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3 Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2 Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2 Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3 Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 2 Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 3

[0] Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism [0] Even Kids With Known Allergies Can Be Safely Vaccinated [0] FDA Demands Tougher Warnings on Immunosuppressive Drugs [0] HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry

Nurturing Our Nurses for Healthcare Par Excellence

...leaner for a Tasmanian school was convicted to a f...the bathroom on film , and making pornography out ...uilty to three counts of indecency, one count of p...aterial, and one count of possessing child exploit...

...ity of Illinois at Chicago explain in the May 11 i... the heart's pacemaker to slow the rapid beating ...aline. A single cell in the upper right chamber i...f the beating heart, triggering its neighbor cells...

...who is at risk for the disease, as well as ways to...n myths about osteoporosis. 1. MYTH: Only women ...ore women who may develop this condition, theres a...portion of men who have this disease, Douyon says....

Other Medicine News:Health News:Nurturing Our Nurses for Healthcare Par Excellence 2 Health News:Nurturing Our Nurses for Healthcare Par Excellence 3 Health News:Nurturing Our Nurses for Healthcare Par Excellence 4 Health News:Slowing the Racing Heart 2 Health News:7 Common Myths About Osteoporosis 2 Health News:7 Common Myths About Osteoporosis 3

Nurturing Our Nurses for Healthcare Par Excellence School-Employed Voyeur Jailed Over Making Pornography Slowing the Racing Heart 7 Common Myths About Osteoporosis

(Date:9/5/2008)...wswire-USNewswire/ -- The Florida,Technology, Rese...a,Atlantic University researcher Dr. Herbert Weiss...Center for Molecular Biology and,Biotechnology in ...,Resources LLC (CHS), $184,294 as part of the Stat... Grant program (SURECAG). SURECAG was,established ...

(Date:9/5/2008)...pt. 5 /- SARcode,Corporatio...-1 inhibitors,to treat inflammatory diseases, and ... announced SARcode,s initiation of a Phase 1 clini...ate for T-cell mediated ophthalmic,diseases. Sunes...oviding,SARcode with an exclusive license to Sunes...

(Date:9/4/2008)...- Cytopia Limited (ASX:,CYT) today an...ase Ib/II,study of CYT997, the company,s novel vas...h an aggressive form of brain cancer known as glio...l is the first Phase II efficacy study in highly,v...nd the second in its,suite of Phase II studies des...

(Date:9/4/2008)...eal-time PCR testing for the diagnostic ...ept. 4 /- The U.S. Food & Drug,Admini...Man(R) HBV Test,the first assay for quantitating ...t uses Roche,s real-time PCR technology to quantif...,s blood. Doctors may use viral load,testing resul...

Breaking Medicine Technology:Major State Grant Accelerates Research and Development of Novel Cancer Therapy 2 Major State Grant Accelerates Research and Development of Novel Cancer Therapy 3 SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2 SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3 Cytopia Commences Second Phase II Study in Brain Cancer 2 Cytopia Commences Second Phase II Study in Brain Cancer 3 FDA Approves First Hepatitis B Viral Load Test 2 FDA Approves First Hepatitis B Viral Load Test 3 Climate change and life in the Southern Ocean 1347 1 Climate change and life in the Southern Ocean 1347 2 Climate change and life in the Southern Ocean 1347 3 Climate change and life in the Southern Ocean 1347 4 AspenBio Pharma Pursues FDA 510 28k 29 Application Pathway for Appendicitis Blood Test 1964 1 AspenBio Pharma Pursues FDA 510 28k 29 Application Pathway for Appendicitis Blood Test 1964 2 AspenBio Pharma Pursues FDA 510 28k 29 Application Pathway for Appendicitis Blood Test 1964 3 AspenBio Pharma Pursues FDA 510 28k 29 Application Pathway for Appendicitis Blood Test 1964 4 Raven Announces Continued Enrollment of Phase 1 2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 924 1 Raven Announces Continued Enrollment of Phase 1 2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 924 2 Raven Announces Continued Enrollment of Phase 1 2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 924 3 U S Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter 922 1 U S Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter 922 2 U S Department of Health and Human Services Completes Funding of 2006 Contract Award to CSCs DVC and Baxter 922 3

[0] Major State Grant Accelerates Research and Development of Novel Cancer Therapy [0] SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases [0] Cytopia Commences Second Phase II Study in Brain Cancer [0] FDA Approves First Hepatitis B Viral Load Test

...nical trial,anticipated later this year, SEATTLE, ...peutics, Inc. (CTI) announced the publication of p...nt with pixantrone (BBR,2778) resulted in minimal ...n and mitoxantrone induced significant cardiac dam... of equiactive doses,of pixantrone to doxorubicin ...

...- Sirtris,Pharmaceuticals, Inc. (NASDAQ: SIRT), a ...nd developing small molecule drugs to treat,diseas...RT1, a,member of the sirtuin family of enzymes, wa...ses such as Alzheimer,s Disease and,Amyotrophic La...ppear in an article published in Volume 26, Number...

Other Medicine Technology:Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2 Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3 Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4 Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5 Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6 Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 2 Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 3

Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease

Products	Sharp Weitlaner Retractor
Company	Spectrum Surgical Instruments Corp.
Item	Sharp Weitlaner Retractor
Features
Description	Sharp Weitlaner Retractor.
Info	Spectrum Surgical Instruments Corp. Customer Service: (800) 444-5644 Web site: http://www.spectrumsurgical.com